Discovery Radiomics via Evolutionary Deep Radiomic Sequencer Discovery
  for Pathologically-Proven Lung Cancer Detection
  While lung cancer is the second most diagnosed form of cancer in men and
women, a sufficiently early diagnosis can be pivotal in patient survival rates.
Imaging-based, or radiomics-driven, detection methods have been developed to
aid diagnosticians, but largely rely on hand-crafted features which may not
fully encapsulate the differences between cancerous and healthy tissue.
Recently, the concept of discovery radiomics was introduced, where custom
abstract features are discovered from readily available imaging data. We
propose a novel evolutionary deep radiomic sequencer discovery approach based
on evolutionary deep intelligence. Motivated by patient privacy concerns and
the idea of operational artificial intelligence, the evolutionary deep radiomic
sequencer discovery approach organically evolves increasingly more efficient
deep radiomic sequencers that produce significantly more compact yet similarly
descriptive radiomic sequences over multiple generations. As a result, this
framework improves operational efficiency and enables diagnosis to be run
locally at the radiologist's computer while maintaining detection accuracy. We
evaluated the evolved deep radiomic sequencer (EDRS) discovered via the
proposed evolutionary deep radiomic sequencer discovery framework against
state-of-the-art radiomics-driven and discovery radiomics methods using
clinical lung CT data with pathologically-proven diagnostic data from the
LIDC-IDRI dataset. The evolved deep radiomic sequencer shows improved
sensitivity (93.42%), specificity (82.39%), and diagnostic accuracy (88.78%)
relative to previous radiomics approaches.
